About Bedaquiline
Class: | Antitubercular agent (specifically a diarylquinoline)
Use: | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) in combination with other antitubercular agents
Adult dose: | 400 mg orally once daily for 2 weeks, followed by 200 mg orally three times a week for 22 weeks
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age
Side effects: | Nausea, headache, fatigue, joint pain, chest pain, and potential QT interval
Drug Class
Antitubercular agent (specifically a diarylquinoline)
Uses & Indications
Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) in combination with other antitubercular agents
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from light and moisture
Manufacturer & Packaging
Manufacturer: Janssen Pharmaceutica N.V., BELGIUM
Package Size
188s
Price & Supplier
Price in UAE: AED 133309.00
Dosage Information
Adult Dose
400 mg orally once daily for 2 weeks, followed by 200 mg orally three times a week for 22 weeks
Pediatric Dose
Safety and efficacy not established in pediatric patients under 18 years of age
Side Effects
Nausea, headache, fatigue, joint pain, chest pain, and potential QT interval prolongation
Contraindications & Precautions
Hypersensitivity to bedaquiline or any component of the formulation; caution in patients with a history of QT prolongation or those on drugs that prolong the QT interval
Important Warnings
Risk of QT prolongation; monitor ECG in patients with risk factors; may cause hepatotoxicity; not recommended for use as a monotherapy; should be used in conjunction with other antitubercular agents to prevent resistance
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.